OPTIONS, RESTRICTED STOCK UNITS AND WARRANTS (Tables)
|
6 Months Ended |
Jun. 30, 2021 |
|---|
| OPTIONS, RESTRICTED STOCK UNITS AND WARRANTS (Tables) [Line Items] |
|
| Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block] |
The following table presents information related to stock options at June 30, 2021:
|
Options Outstanding
|
|
|
Options Exercisable
|
|
| |
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
Average
|
|
|
Exercisable
|
|
|
Exercise
|
|
|
Number of
|
|
|
Remaining Life
|
|
|
Number of
|
|
|
Price
|
|
|
Options
|
|
|
In Years
|
|
|
Options
|
|
|
$
|
2.51-5.00 |
|
|
|
2,447,257 |
|
|
|
7.2 |
|
|
|
1,545,675 |
|
| |
5.01-7.50 |
|
|
|
1,289,032 |
|
|
|
5.9 |
|
|
|
1,013,760 |
|
| |
7.51-10.00 |
|
|
|
203,333 |
|
|
|
8.2 |
|
|
|
115,133 |
|
| |
10.01-12.50 |
|
|
|
65,000 |
|
|
|
8.9 |
|
|
|
48,332 |
|
| |
|
|
|
|
4,004,622 |
|
|
|
6.9 |
|
|
|
2,722,900 |
|
|
Options Outstanding
|
|
|
Options Exercisable
|
|
| |
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
Average
|
|
|
Exercisable
|
|
|
Exercise
|
|
|
Number of
|
|
|
Remaining Life
|
|
|
Number of
|
|
|
Price
|
|
|
Options
|
|
|
In Years
|
|
|
Options
|
|
|
$
|
5.00 |
|
|
|
675,000 |
|
|
|
8.17 |
|
|
|
616,665 |
|
|
| Share-based Payment Arrangement, Option, Activity [Table Text Block] |
A summary of the stock option activity and related information for the Plan for the six months ended June 30, 2021 is as follows:
| |
|
|
|
|
|
|
|
|
|
Weighted-Average
|
|
|
|
|
|
| |
|
|
|
|
|
Weighted-Average
|
|
|
Remaining
|
|
|
Aggregate
|
|
| |
|
Shares
|
|
|
Exercise Price
|
|
|
Contractual Term
|
|
|
Intrinsic Value
|
|
|
Outstanding at December 31, 2020
|
|
|
3,568,497 |
|
|
$
|
5.59 |
|
|
|
7.0 |
|
|
$
|
110,961 |
|
|
Grants
|
|
|
754,500 |
|
|
|
4.14 |
|
|
|
10.0 |
|
|
$
|
-
|
|
|
Exercised
|
|
|
(9,375 |
)
|
|
$
|
2.96 |
|
|
|
|
|
|
|
-
|
|
|
Forfeited/expired
|
|
|
(309,000 |
)
|
|
$
|
7.23 |
|
|
|
|
|
|
|
-
|
|
|
Outstanding at June 30, 2021
|
|
|
4,004,622 |
|
|
$
|
5.20 |
|
|
|
6.9 |
|
|
$
|
190,635 |
|
|
Exercisable at June 30, 2021
|
|
|
2,722,900 |
|
|
$
|
5.35 |
|
|
|
5.8 |
|
|
$
|
66,322 |
|
|
| Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] |
The following assumptions were used in determining the fair value of options during the six months ended June 30, 2021:
|
Risk-free interest rate
|
|
|
0.83% - 1.30
|
%
|
|
Dividend yield
|
|
|
0 |
% |
|
Stock price volatility
|
|
|
89.23% to 95.98 |
% |
|
Expected life
|
|
6 years |
|
|
Weighted average grant date fair value
|
|
$
|
3.63 |
|
|
Risk-free interest rate
|
|
|
0.05% - 0.25
|
%
|
|
Dividend yield
|
|
|
0 |
%
|
|
Stock price volatility
|
|
|
88.57 |
%
|
|
Expected life
|
|
0.25– 2 years |
|
|
Risk-free interest rate
|
|
|
0.06% - 0.46
|
%
|
|
Dividend yield
|
|
|
0 |
%
|
|
Stock price volatility
|
|
|
88.59 |
%
|
|
Expected life
|
|
0.59– 3 years |
|
|
Risk-free interest rate
|
|
|
0.07% - 0.46
|
%
|
|
Dividend yield
|
|
|
0 |
%
|
|
Stock price volatility
|
|
|
88.59 |
%
|
|
Expected life
|
|
1.25- 3 years |
|
|
| Schedule of Warrants or Rights, Shares Authorized, by Exercise Price Range [Table Text Block] |
The following table summarizes information with respect to outstanding warrants to purchase common stock of BioSig Technologies, Inc. at June 30, 2021:
|
Exercise
|
|
|
Number
|
|
Expiration
|
|
Price
|
|
|
Outstanding
|
|
Date
|
|
$
|
4.80 |
|
|
|
125,000 |
|
February 2025 |
|
$
|
6.16 |
|
|
|
568,910 |
|
November 2027 |
|
$
|
6.85 |
|
|
|
193,352 |
|
July 2021 to August 2021 |
| |
|
|
|
|
887,262 |
|
|
|
| Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] |
A summary of the warrant activity for the six months ended June 30, 2021 is as follows:
| |
|
|
|
|
|
|
|
|
|
Weighted-Average
|
|
|
|
|
|
| |
|
|
|
|
|
Weighted-Average
|
|
|
Remaining
Contractual
|
|
|
Aggregate
|
|
| |
|
Shares
|
|
|
Exercise Price
|
|
|
Term
|
|
|
Intrinsic Value
|
|
|
Outstanding at December 31, 2020
|
|
|
1,446,200 |
|
|
$ |
5.44 |
|
|
|
3.3 |
|
|
$ |
1,500 |
|
|
Grants
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercised
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expired
|
|
|
(558,938 |
)
|
|
$ |
4.36 |
|
|
|
- |
|
|
|
- |
|
|
Outstanding at June 30, 2021
|
|
|
887,262 |
|
|
$ |
6.12 |
|
|
|
4.6 |
|
|
$ |
- |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vested and expected to vest at June 30, 2021
|
|
|
887,262 |
|
|
$ |
6.12 |
|
|
|
4.6 |
|
|
$ |
- |
|
|
Exercisable at June 30, 2021
|
|
|
887,262 |
|
|
$ |
6.12 |
|
|
|
4.6 |
|
|
$ |
- |
|
|
| Nonvested Restricted Stock Shares Activity [Table Text Block] |
The following table summarizes the restricted stock activity for the six months ended June 30, 2021:
|
Restricted shares issued as of December 31, 2020
|
|
|
218,334 |
|
|
Granted
|
|
|
251,000 |
|
|
Vested and issued
|
|
|
(77,084 |
)
|
|
Forfeited
|
|
|
(100,000 |
)
|
|
Total
|
|
|
292,250 |
|
|
Comprised of:
|
|
|
|
|
|
Vested restricted shares as of June 30, 2021
|
|
|
50,000 |
|
|
Unvested restricted shares as of June 30, 2021
|
|
|
242,250 |
|
|
Total
|
|
|
292,250 |
|
|
Restricted shares issued as of December 31, 2020
|
|
|
1,420,716 |
|
|
Granted
|
|
|
- |
|
|
Issued
|
|
|
(40,000 |
)
|
|
Forfeited
|
|
|
(82,716 |
)
|
|
Total
|
|
|
1,298,000 |
|
|
Comprised of:
|
|
|
|
|
|
Vested restricted shares as of June 30, 2021
|
|
|
818,000 |
|
|
Unvested restricted shares as of June 30, 2021
|
|
|
480,000 |
|
|
Total
|
|
|
1,298,000 |
|
|
| Schedule of Warrants or Rights, Shares Authorized, Exercise Price Range [Table Text Block] |
The following table presents information related to warrants (ViralClear) at June 30, 2021:
|
Exercise
|
|
|
Number
|
|
Expiration
|
|
Price
|
|
|
Outstanding
|
|
Date
|
|
$
|
5.00 |
|
|
|
473,772 |
|
November 2027 |
| |
10.00 |
|
|
|
6,575 |
|
May 2025 |
| |
|
|
|
|
480,347 |
|
|
|
| Viral Clear [Member] |
|
| OPTIONS, RESTRICTED STOCK UNITS AND WARRANTS (Tables) [Line Items] |
|
| Share-based Payment Arrangement, Option, Activity [Table Text Block] |
A summary of the stock option activity and related information for the ViralClear Plan for the six months ended June 30, 2021 is as follows:
| |
|
|
|
|
|
|
|
|
|
Weighted-Average
|
|
| |
|
|
|
|
|
Weighted-Average
|
|
|
Remaining
Contractual
|
|
| |
|
Shares
|
|
|
Exercise Price
|
|
|
Term
|
|
|
Outstanding at December 31, 2020
|
|
|
1,527,666 |
|
|
$ |
5.00 |
|
|
|
3.96 |
|
|
Grants
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
Exercised
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
Forfeited/expired
|
|
|
(852,666 |
)
|
|
$ |
5.00 |
|
|
|
|
|
|
Outstanding at June 30, 2021
|
|
|
675,000 |
|
|
$ |
5.00 |
|
|
|
8.17 |
|
|
Exercisable at June 30, 2021
|
|
|
616,665 |
|
|
$ |
5.00 |
|
|
|
8.11 |
|
|